Gadolinium-loaded nanoparticles engineered from microemulsion templates

被引:55
作者
Oyewumi, MO [1 ]
Mumper, RJ [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
基金
美国国家科学基金会;
关键词
Brij; 72; emulsifying wax; gadolinium acetylacetonate; neutron capture therapy; polysorbate;
D O I
10.1081/DDC-120002847
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microemulsions (oil-in-water) have been used as templates to engineer stable emulsifying wax and Brij 72 (polyoxyl 2 stearyl ether) nanoparticles. The technique is simple, reproducible, and amenable to large-scale production of stable nanoparticles having diameters below 100 nm. Investigation of the process variables showed that the amount of surfactant used in the preparation of microemulsion templates had the greatest influence on the microemulsion window, as well as the properties and stability of the cured nanoparticles. Emulsifying wax and Brj 72 nanoparticles (2 mg/mL) made with 3 mM polyoxyl 20 stearyl ether and 2.3 mM polysorbate 80, respectively, were the most stable based on retention of nanoparticle size over time. Gadolinium acetylacetonate (GdAcAc), a potential anticancer agent for neutron capture therapy (NCT), was entrapped in stable nanoparticles. The apparent water solubility of GdAcAc was increased more than 2000-fold by entrapment into nanoparticles. The entrapment efficiency of GdAcAc was about 100% for emulsifying wax nanoparticles and 86% for Brij 72 nanoparticles, as determined by gel permeation chromatography (GPC). Elution profiles were obtained with light scattering (counts per second) to detect nanoparticles and ultraviolet (UV) absorption qf'GdAcAc at 288 nm. Challenges of these cured nanoparticles in biologically relevant media such as 10% fetal bovine serum, 10 mM phosphate-buffered saline, 150 mM NaCl, and 10% lactose at 37degreesC for 60 min demonstrated that these nanoparticles are stable. The ease of preparation of these very small and stable nanoparticles, and the ability to entrap lipophilic drugs such as GdAcAc with high efficiency, suggested that these systems may have potential in cell targeting, especially for specific delivery to tumor cells for NCT.
引用
收藏
页码:317 / 328
页数:12
相关论文
共 30 条
  • [1] TRANSFER OF LIPOSOMAL DRUG CARRIERS FROM THE BLOOD TO THE PERITONEAL-CAVITY OF NORMAL AND ASCITIC TUMOR-BEARING MICE
    BALLY, MB
    MASIN, D
    NAYAR, R
    CULLIS, PR
    MAYER, LD
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (02) : 137 - 146
  • [2] BORON NEUTRON-CAPTURE THERAPY OF PRIMARY AND METASTATIC BRAIN-TUMORS
    BARTH, RF
    SOLOWAY, AH
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1994, 21 (2-3) : 139 - 154
  • [3] BHARGRAVE NH, 1987, PHARM TECH, V11, P46
  • [4] Brown JM, 1998, CANCER RES, V58, P1408
  • [5] Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
    Cavalli, R
    Caputo, O
    Carlotti, ME
    Trotta, M
    Scarnecchia, C
    Gasco, MR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (01) : 47 - 54
  • [6] LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS
    CONSTANTINIDES, PP
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (11) : 1561 - 1572
  • [7] DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
  • [8] Effect of bovine serum on the phase transition temperature of cholesterol-containing liposomes
    Gaber, MH
    [J]. JOURNAL OF MICROENCAPSULATION, 1998, 15 (02) : 207 - 214
  • [9] Gasco M.R., 1997, PHARM TECHNOL EUR, V9, P52
  • [10] Defining the drug incorporation properties of PLA-PEG nanoparticles
    Govender, T
    Riley, T
    Ehtezazi, T
    Garnett, MC
    Stolnik, S
    Illum, L
    Davis, SS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) : 95 - 110